QIAGEN N.V. (QGEN) recently launched 35 new wet-lab tested dPCRs for its digital PCR (dPCR) platform QIAcuity. The new assays are available on the GeneGlobe research platform and are designed to target a wide range of pathogens responsible for tropical diseases, sexually transmitted infections (STIs) and urinary tract infections (UTIs). The latest development further strengthens QIAGEN's position as a leader in microbial detection and analysis. This is also likely to significantly boost its Life Sciences bu ...